Poo transplants beat antibiotics for treating C. diff superbug
Neewilly Emmanuel Kweh
Nov. 05, 2019
Treating recurrent infections caused by superbug Clostridium difficile using faecal microbiota (poo) transplants rather than antibiotics increased survival by around a third, cut time spent in hospital by half, and reduced the risk of sepsis by nearly four times, according to European scientists. They looked at outcomes for 290 patients with recurrent C. diff infections, 109 of whom were treated with a faecal transplant, and 181 of whom received antibiotics.
Funder: No specific funding.
Treating recurrent C diff with fecal transplant increased survival, cut hospital stays, and reduced the risk of sepsis compared to treatment with antibiotics
Treating recurrent Clostridioides difficile (CDI) with fecal microbiota transplantation (FMT) increased survival by nearly 30 percent, cut length of hospital stay in half, and reduced the risk of sepsis by nearly four times compared to treating with antibiotics. Findings from a prospective cohort study are published in Annals of Internal Medicine.
Recurrent CDI is often antibiotic-resistant and is associated with life-threatening complications, including bloodstream infections. A substantial proportion of patients with CDI are likely to develop bloodstream infections, most of which are caused by intestinal microbes and lead to death in more than 50 percent of patients. Fecal microbiota transplantation (FMT) is more effective than antibiotics in treating recurrent CDI, but its efficacy in preventing CDI-related BSI is uncertain.
Researchers from the Fondazione Policlinico Gemelli IRCCS, an academic tertiary centre in Rome, Italy, compared outcomes for 290 patients hospitalized with recurrent CDI who were treated with either FMT (n=109) or antibiotics (n=181). Five patients in the FMT group and 22 in the antibiotic group developed a bloodstream infection. Because of differences in the patients treated with FMT versus antibiotics in many baseline characteristics, including number of recurrences and CDI severity, comparative analyses were limited to a matched cohort. Risk for bloodstream infection was 23 percentage points lower in the FMT group and the FMT group also had 14 fewer days of hospitalization and a 32-percentage point increase in overall survival at 90 days compared with the antibiotic group. According to the researchers, these findings suggest that FMT may be an option not only for curing recurrent CDI but also for preventing its complications.
Referendum coming soon just after corona storm, says RailaHow a post-COVID-19 revival could kickstart Africa’s free trade areaThis is how coronavirus lockdowns have changed energy demandCOVID-19: Sports Ministry to disburse Sh50million to athletes over two monthsHard watching leagues resume while English game suspended - Mourinho